
|Articles|December 1, 2015
Orphan Drug Market Growth Through 2019
Advertisement
Research and Markets released its report Global Orphan Drugs Market 2015-2019, forecasting the market to grow at a CAGR of 10.05% over the period 2014-2019.
Research analysts noted emerging trends in the orphan drug market are a focus on biologics, shorter drug development timelines, and the challenges of enrollment. Conducting clinical trials in rare diseases with smaller number of patients available for clinical studies is around recruiting enough patients to generate significant comparative data.
Read the full
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Patient Preferences in Remote Trials, Sanofi’s Neurology and Immunology Deals, and AI-Driven Biomarkers in Oncology
2
Life Sciences Can’t Afford Fragmented Data and Disconnected Teams
3
ACT Brief: Rethinking Site Support in 2026, GSK’s New Severe Asthma Approval, and Priority Review Momentum in Multiple Myeloma
4
How Sourcing Decisions Shape Site Experience and Study Execution
5




